Medikit (7749) · FactRestated
Change of President and Representative Director and Restructuring of the Officer Structure
First written in FY2021. 1 of 2 entries say "Restated". Latest entry: FY2022.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Change of Representative Director, President and CEO and Transition to Successor Management StructureA theme 254 companies write about · 1 as a headwind · 28 as a tailwind
26 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 257 threads.Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「June 2021: Appointed representative director and president (incumbent)」
The Company confirmed in the executive biographies that the representative director and president who took office in FY2021 remained incumbent as of the submission date. - FY2021First statedAnnual report
「June 2021: Appointed representative director and president (incumbent)」
Following the Annual General Meeting of Shareholders in June 2021, Kageyama Yoji (景山 洋二) became representative director and president, and the officer structure, including the vice president and directors in charge, was updated.